330.27
price down icon2.85%   -9.70
after-market After Hours: 330.01 -0.26 -0.08%
loading

Madrigal Pharmaceuticals Inc Stock (MDGL) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
29.75%
152.04
117.18 98.53 86.45 78.34
Interest Income/Expense
3.35%
3.838
3.971 3.504 2.901 2.336
Operating Income/Loss
29.75%
-152.04
-117.18 -98.53 -86.45 -78.34
Income/Loss From Continuing Operations Before Tax
31.51%
-147.54
-112.19 -98.74 -85.80 -76.90
Income/Loss From Continuing Operations After Tax
31.51%
-147.54
-112.19 -98.74 -85.80 -76.90
Net Income/Loss
31.51%
-147.54
-112.19 -98.74 -85.80 -76.90
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.22%
20.00
19.76 18.48 18.31 18.19
Diluted Average Shares
1.22%
20.00
19.76 18.48 18.31 18.19
Basic Earnings Per Share
29.93%
-7.38
-5.68 -5.34 -4.69 -4.23
Diluted Earnings Per Share
29.93%
-7.38
-5.68 -5.34 -4.69 -4.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):